In order to stay competitive in the biopharmaceutical industry, companies are increasingly turning to outsourcing as a means of gaining an advantage. With the many competing Contract Development and Manufacturing Organizations (CDMOs) and Contract Research...
The race to first-in-human clinical trials has become more critical than ever for drug developers. The FDA has even developed 4 major tracks to speed up the process and make drugs available to patients as fast as possible: Fast Track: Facilitates drug development and...
Throughout the year, ChemPartner attends events and conferences around the world not only to stay up to date with the latest trends but to share our expertise with the industry. Mark your calendar with this year’s top biopharma conferences and events, and be...
The combined small and large molecule Contract Development and Manufacturing Organization (CDMO) market was valued at $52.8 billion dollars in 2021 with annual growth rates of 6.5% and 8.6% (respectively) from 2022 to 2030. So, why are more and more biotech and...